Information Provided By:
Fly News Breaks for November 10, 2019
NKTR
Nov 10, 2019 | 20:07 EDT
Piper Jaffray analyst Tyler Van Buren maintained an Overweight rating and $35 price target on Nektar shares after the company's PIVOT-02 study update at SITC. In a note to investors titled "SITC Update Continues To Suggest That The Melanoma Phase III Should Succeed," the analyst said the data was "largely consistent with the ASCO presentation" and "a positive incremental update."
News For NKTR From the Last 2 Days
There are no results for your query NKTR